FDA.reportPublic FDA data

LaMICtal XR Patient Titration Kit Blue 25 MG (21), 50 MG (7) 28 Count

RxCUI
900984
RxNorm name
LaMICtal XR Patient Titration Kit Blue 25 MG (21), 50 MG (7) 28 Count
Display name
LaMICtal XR Patient Titration Kit Blue 25 MG (21), 50 MG (7) 28 Count
Full name
LaMICtal XR Patient Titration Kit Blue 25 MG (21), 50 MG (7) 28 Count
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:54

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LAMICTAL XRLAMOTRIGINEGlaxoSmithKline LLC3e2c9a35-6a39-41d7-ad84-3c0bb8894b092025-10-10Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 900984

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3e2c9a35-6a39-41d7-ad84-3c0bb8894b09{21 (24 HR lamotrigine 25 MG Extended Release Oral Tablet [Lamictal]) / 7 (24 HR lamotrigine 50 MG Extended Release Oral Tablet [Lamictal]) } Pack [Lamictal XR Blue Patient Titration Kit (for Patients Taking Valproate)] [BPCK] · LaMICtal XR Patient Titration Kit Blue 25 MG (21), 50 MG (7) 28 Count [PSN] · Lamictal XR Blue Patient Titration Kit [SY] · Lamictal XR Blue Patient Titration Kit (for Patients Taking Valproate) [SY]443These highlights do not include all the information needed to use LAMICTAL XR safely and effectively. See full prescribing information for LAMICTAL XR. LAMICTAL XR (lamotrigine) extended-release tablets, for oral use Initial U.S. Approval: 199420251010